Please rewrite and optimize this data extraction form: Stem Cell Transplant Data…
- User
Please rewrite and optimize this data extraction form: Stem Cell Transplant Data Extraction Form
- Patient Information Variable Value Units (if applicable) Patient ID National Code Date of Birth (Age at transplant) years Gender Height cm Weight kg BMI kg/m² Race/Ethnicity
- Disease and Transplant Details Variable Value Date (if applicable) Primary Diagnosis Date of Diagnosis Disease Status at Transplant Type of Transplant (Autologous/Allogeneic) Date of Transplant Stem Cell Source HLA Matching (if allogeneic) out of 10 Donor Relationship (if allogeneic) Conditioning Regimen Graft Manipulation (Yes/No, specify)
- Pre-Transplant Assessment 3.1 Hematological Parameters Parameter At Diagnosis Pre-Transplant Units WBC count x10⁹/L Hemoglobin g/dL Neutrophil count x10⁹/L Lymphocyte count x10⁹/L Monocyte count x10⁹/L Platelet count x10⁹/L
3.2 Biochemical Parameters Parameter Value Reference Range ALT U/L AST U/L BUN mg/dL Creatinine mg/dL Total Protein g/dL Albumin g/dL Calcium mg/dL Phosphorus mg/dL Ferritin ng/mL PTH pg/mL HDL Cholesterol mg/dL LDL Cholesterol mg/dL Triglycerides mg/dL Total Cholesterol mg/dL 3.3 Infectious Disease Markers Test Result (Positive/Negative) Date Titer/Value (if applicable) CMV IgG CMV IgM HSV IgG VZV IgG VZV IgM EBV IgG EBV IgM HBs Ab HBs IgM HBc Ab HBe Ab H. pylori IgG H. pylori IgA Toxoplasma IgG HIV antibody PPD test 4. Donor Information (for allogeneic transplants) Parameter Value Units WBC count x10⁹/L Hemoglobin g/dL Neutrophil count x10⁹/L Lymphocyte count x10⁹/L Monocyte count x10⁹/L Platelet count x10⁹/L Stem cell dose (MNC or CD34+) 5. Early Complications due to Transplant Complication Onset Date Severity Treatment Infections Acute GvHD (grade) Bronchiolitis Other (specify) 6. Pre-existing Conditions and Lifestyle Factors Factor Details Comorbidities Smoking Status 7. Prior Treatments Treatment Start Date End Date Response 1. 2. 3. 8. Long-term Follow-up and Survival Analysis (5-year period) 8.1 Overall Survival (OS) Parameter Value Date (if applicable) Survival Status at 5 years (Alive/Dead) Date of Death (if applicable) Cause of Death (if applicable) Time to Death (days from transplant) 8.2 Progression-Free Survival (PFS) Parameter Value Date (if applicable) Disease Status at 5 years (Progression/No Progression) Date of Progression (if applicable) Time to Progression (days from transplant) 8.3 Follow-up Assessments Parameter 30 days 100 days 6 months 1 year 5 years Disease status Chimerism (%) Key complications ECOG Performance Status Graft function 8.4 Late Effects and Long-term Complications Complication Onset Date Severity Treatment Resolved (Y/N) Chronic GvHD Secondary malignancies Endocrine dysfunction Cardiovascular complications Pulmonary complications Bone/joint complications Other (specify) 8.5 Subsequent Treatments Treatment Start Date End Date Reason Response 1. 2. 3. 4.
- Assistant
Optimized Stem Cell Transplant Data Extraction Form
Section 1: Patient Information
Variable Value Units Patient ID National Code Date of Birth YYYY-MM-DD Age at Transplant Years Gender M/F/Other Race/Ethnicity Height cm Weight kg BMI kg/m²
Section 2: Disease and Transplant Details
Variable Value Date (if applicable) Units Primary Diagnosis Date of Diagnosis YYYY-MM-DD Disease Status at Transplant Type of Transplant Autologous / Allogeneic Date of Transplant YYYY-MM-DD Stem Cell Source Conditioning Regimen Graft Manipulation Yes / No (If Yes, specify) If Allogeneic Transplant:
Variable Value Units HLA Matching Matches out of 10 Donor Relationship
Section 3: Pre-Transplant Assessment
3.1 Hematological Parameters
Parameter At Diagnosis Pre-Transplant Units WBC Count ×10⁹/L Hemoglobin g/dL Neutrophil Count ×10⁹/L Lymphocyte Count ×10⁹/L Monocyte Count ×10⁹/L Platelet Count ×10⁹/L 3.2 Biochemical Parameters
Parameter Value Reference Range Units ALT U/L AST U/L BUN mg/dL Creatinine mg/dL Total Protein g/dL Albumin g/dL Calcium mg/dL Phosphorus mg/dL Ferritin ng/mL PTH pg/mL HDL Cholesterol mg/dL LDL Cholesterol mg/dL Triglycerides mg/dL Total Cholesterol mg/dL 3.3 Infectious Disease Markers
Test Result (Positive/Negative) Date (YYYY-MM-DD) Titer/Value (if applicable) CMV IgG CMV IgM HSV IgG VZV IgG VZV IgM EBV IgG EBV IgM HBs Ab HBs IgM HBc Ab HBe Ab H. pylori IgG H. pylori IgA Toxoplasma IgG HIV Antibody PPD Test
Section 4: Donor Information (Allogeneic Transplants Only)
Parameter Value Units WBC Count ×10⁹/L Hemoglobin g/dL Neutrophil Count ×10⁹/L Lymphocyte Count ×10⁹/L Monocyte Count ×10⁹/L Platelet Count ×10⁹/L Stem Cell Dose Specify (MNC or CD34+)
Section 5: Early Complications Post-Transplant
Complication Onset Date (YYYY-MM-DD) Severity (Grade) Treatment Provided Infections Acute GvHD Grade I–IV Bronchiolitis Other (Specify)
Section 6: Pre-Existing Conditions and Lifestyle Factors
Factor Details Comorbidities (List any pre-existing conditions) Smoking Status Never / Former / Current Alcohol Use Never / Occasional / Regular Other Factors (Specify)
Section 7: Prior Treatments
Treatment Start Date (YYYY-MM-DD) End Date (YYYY-MM-DD) Response (CR/PR/SD/PD) 1. 2. 3. Abbreviations:
- CR: Complete Response
- PR: Partial Response
- SD: Stable Disease
- PD: Progressive Disease
Section 8: Long-Term Follow-Up and Survival Analysis (Up to 5 Years)
8.1 Overall Survival (OS)
Parameter Value Date (YYYY-MM-DD) Survival Status at 5 Years Alive / Deceased Date of Death Cause of Death (Specify) Time to Death Days from Transplant 8.2 Progression-Free Survival (PFS)
Parameter Value Date (YYYY-MM-DD) Disease Status at 5 Years Progression / No Progression Date of Progression Time to Progression Days from Transplant 8.3 Follow-Up Assessments
Record at Each Time Point
Parameter 30 Days 100 Days 6 Months 1 Year 5 Years Disease Status Chimerism (%) Key Complications ECOG Performance Status Graft Function 8.4 Late Effects and Long-Term Complications
Complication Onset Date (YYYY-MM-DD) Severity (Grade) Treatment Provided Resolved (Y/N) Chronic GvHD Secondary Malignancies Endocrine Dysfunction Cardiovascular Issues Pulmonary Complications Bone/Joint Problems Other (Specify) 8.5 Subsequent Treatments
Treatment Start Date (YYYY-MM-DD) End Date (YYYY-MM-DD) Reason for Treatment Response (CR/PR/SD/PD) 1. 2. 3. 4.
Additional Notes
-
Data Entry Instructions:
- Use YYYY-MM-DD format for all dates.
- Ensure all numeric values include units.
- For any unavailable data, mark as N/A.
- Use official grading scales (e.g., CTCAE) for severity.
- Maintain patient confidentiality at all times.
-
Abbreviations:
- WBC: White Blood Cell
- GvHD: Graft-versus-Host Disease
- ECOG: Eastern Cooperative Oncology Group
- MNC: Mononuclear Cells
- CD34+: Cluster of Differentiation 34 Positive Cells
- ALT: Alanine Aminotransferase
- AST: Aspartate Aminotransferase
- BUN: Blood Urea Nitrogen
- PTH: Parathyroid Hormone
-
Performance Status Scale:
- ECOG 0: Fully active
- ECOG 1: Restricted in physically strenuous activity
- ECOG 2: Ambulatory, capable of all self-care
- ECOG 3: Limited self-care
- ECOG 4: Completely disabled
Instructions for Data Collectors
- Accuracy: Double-check all entries for accuracy and completeness.
- Consistency: Use consistent units and terminologies throughout the form.
- Clarifications: Refer to clinical records or consult with healthcare providers if any information is unclear.
- Updates: Keep records updated with the latest follow-up information.
- Confidentiality: Handle all patient data in compliance with HIPAA and institutional guidelines.
By optimizing the structure and clarity of this form, data collection becomes more efficient and reliable, facilitating better patient care and research outcomes.